Last reviewed · How we verify

NCT07090720

Melatonin Effects on the Left Ventricular Function in Neonates With Persistent Pulmonary Hypertension

Completed NA Last updated 29 July 2025
What this trial tests

NA trial testing Melatonin in Melatonin in 80 participants. Completed in 1 January 2025.

Timeline
1 January 2023
Primary endpoint
1 January 2025
1 January 2025

Quick facts

Lead sponsorTanta University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment80
Start date1 January 2023
Primary completion1 January 2025
Estimated completion1 January 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

36 Weeks and older, any sex, with Melatonin or Left Ventricular Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the effect of melatonin on the left ventricular function in neonates with persistent pulmonary hypertension

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Melatonin effects on the left ventricular function in neonates with persistent pulmonary hypertension.
    Nofal SM, El-Mashad AM, Elmesiry AM, Abouelenain AM, et al · · 2026 · PMID 41954764 · DOI 10.1007/s00431-026-06864-z

Verify or expand the search:

Other trials of Melatonin

Trials testing the same drug.

Other recruiting trials for Melatonin

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07090720.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing